Replies to post #123906 on NanoViricides Inc. (NNVC)

[Trendliner]

Question for drkazmd64

Your posts are always worth reading. Can you expand on the idea of how they will get into clinical trials soon if no lead candidate has been selected yet, which must occur before toxicology studies are done which must precede any clinical trials?

What am I missing here?

Thanks in advance for your response.

Trendliner

PS The technical picture took a decidedly negative turn this week with the breakdown from a converging consolidation pattern that began May 12th. A support zone between 1.45 and 1.55 remains intact so far. When and if that fails a downside price target of 80-90 cents will be operative.

[JG36]

Almost there???!!!

Herpescide is where Flucide was 5 years ago. And there are no clinical trials in sight for Flucide.

There will be no clinical trials for Herpescide in 2016 or 2017. Bank on it.